Treatment of multiple organ failure through sepsis by surgery and blood purification

Therapeutic Apheresis and Dialysis

Volumn 8, Issue 3, 2004, Pages 185-189

  Asanuma, Yoshihiro ^a   Sato, Tsutomu ^a   Kotanagi, Hitoshi ^a   Yamamoto, Yuzo ^a   Nakae, Hajime ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

APACHE II; Blood purification; Multiple organ failure; PMX; Sepsis

Indexed keywords

ENDOTOXIN; POLYMYXIN B;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PERIOPERATIVE PERIOD; PERITONITIS; PLASMAPHERESIS; PRIORITY JOURNAL; SEPSIS; SURVIVAL; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; APACHE; FEMALE; HEMODIAFILTRATION; HEMOFILTRATION; HUMANS; JAPAN; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PERITONITIS; PLASMA EXCHANGE; POLYMYXINS; SEPSIS; SURVIVAL ANALYSIS; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 3142546253     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-0968.2004.00145.x     Document Type: Conference Paper

References (14)

1. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American College of chest physicians/society of critical care medicine consensus conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
2. Christou N, Barie P, Dellinger EP, Waymack JP, Stone HH. Surgical infection society intra-abdominal infection study. Arch Surg 1993;128:193-9.
3. Bohnen J, Boulanger M, Meakins J, McLean APH. Prognosis in generalized peritonitis. Arch Surg 1983;118:285-90.
4. Zimmerman J, Knaus W, Wagner D et al. A comparison of risks and outcomes for patients with organ system failure: 1982-90. Crit Care Med 1996;24:1633-41.
5. Fagon JY, Chastre J, Novara A, Medioni P, Gibert C. Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Int Care Med 1993;19:137-44.
6. Asanuma Y, Furuya T, Shibata S et al. Postoperative acute pulmonary thromboembolism in patients with acute necrotizing pancreatitis with special reference to apheresis therapy. Ther Apher 1998;2:199-204.
7. Tani T, Hanasawa K, Kodama M et al. Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients. World J Surg 2001;25:660-8.
8. Hirasawa H, Sugai T, Ohtake Y et al. Blood purification for prevention and treatment of multiple organ failure. World J Surg 1996;20:482-6.
9. Nakae H, Asanuma Y, Tajimi K. Cytokine removal by plasma exchange with continuous hemodiafiltration in critically ill patients. Ther Apher 2002;6:419-24.
10. Knaus W, Draper E, Wagner D et al. APACHE II. A severity of disease classification system. Crit Care Med 1985;13:818-29.
11. Deitch E. Multiple Organ Failure: Pathophysiology and potential future therapy. Ann Surg 1992;216:117-34.
12. Remick D, Call D, Ebong S et al. Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality. Crit Care Med 2001;29:473-81.
13. Nakamura T, Ebihara I, Shimada N, Koide H. Changes in plasma erythropoietin and interleukin-6 concentrations in patients with septic shock after hemoperfusion with polymyxin B-immobilized fiber. Int Care Med 1998;24:1272-6.
14. Wang Y, Liu Y, Sarker KP et al. Polymyxin B binds to anandamide and inhibits its cytotoxic effect. FEBS Lett 2000;470:151-5.